Abstract | OBJECTIVE: METHODS AND RESULTS: CONCLUSIONS:
|
Authors | Masashi Fujita, Hiroko Okuda, Osamu Tsukamoto, Yoshihiro Asano, Yulin Liao Akio Hirata, Jiyoong Kim, Takeshi Miyatsuka, Seiji Takashima, Tetsuo Minamino, Hitonobu Tomoike, Masafumi Kitakaze |
Journal | Arteriosclerosis, thrombosis, and vascular biology
(Arterioscler Thromb Vasc Biol)
Vol. 26
Issue 10
Pg. e138-42
(Oct 2006)
ISSN: 1524-4636 [Electronic] United States |
PMID | 16888237
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Angiotensin II Type 1 Receptor Blockers
- Benzimidazoles
- Biphenyl Compounds
- Imidazoles
- NF-kappa B
- RNA, Messenger
- Receptor for Advanced Glycation End Products
- Receptors, Immunologic
- Tetrazoles
- Tumor Necrosis Factor-alpha
- Vascular Cell Adhesion Molecule-1
- olmesartan
- candesartan
|
Topics |
- Angiotensin II Type 1 Receptor Blockers
(pharmacology)
- Benzimidazoles
(pharmacology)
- Biphenyl Compounds
- Cells, Cultured
- Endothelial Cells
(drug effects, metabolism)
- Gene Silencing
- Humans
- Imidazoles
(pharmacology)
- NF-kappa B
(antagonists & inhibitors, metabolism)
- Promoter Regions, Genetic
- RNA Interference
- RNA, Messenger
(antagonists & inhibitors, metabolism)
- Receptor for Advanced Glycation End Products
- Receptors, Immunologic
(antagonists & inhibitors, genetics)
- Tetrazoles
(pharmacology)
- Tumor Necrosis Factor-alpha
(pharmacology)
- Umbilical Veins
(cytology)
- Vascular Cell Adhesion Molecule-1
(genetics, metabolism)
|